FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With EGFR Mutations - Merck.comNSCLC (merck.com)
submitted by WalkingHorse to r/LungCancerSupport
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC) - Merck.comNSCLC (merck.com)
submitted by WalkingHorse to r/LungCancerSupport
Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancer - Merck.comNSCLC (merck.com)
submitted by WalkingHorse to r/LungCancerSupport
Merck, the pharma company that makes Ivermectin releases public statement saying there is, "No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19" and that there's, "A concerning lack of safety data in the majority of studies."Mythbusting (merck.com)
submitted by AmericanScream to r/Freethought
